These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9817526)

  • 1. Failure of pristinamycin treatment in a case of pneumonia caused by a streptogramins B-type resistant pneumococcus.
    Brevet-Coupe F; Guerin B; Watine J
    Scand J Infect Dis; 1998; 30(4):419-20. PubMed ID: 9817526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.
    Cattoir V; Merabet L; Legrand P; Soussy CJ; Leclercq R
    J Antimicrob Chemother; 2007 May; 59(5):1010-2. PubMed ID: 17434877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of pristinamycin treatment in a case of pneumococcal pneumonia.
    Burucoa C; Pasdeloup T; Chapon C; Fauchère JL; Robert R
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):341-2. PubMed ID: 7649198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae].
    Alonso Manzanares MA; Gutíerrez Zufiaurre MN; Muñoz Bellido JL; García-Rodríguez JA
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157
    [No Abstract]   [Full Text] [Related]  

  • 5. Streptogramins - two are better than one!
    Mast Y; Wohlleben W
    Int J Med Microbiol; 2014 Jan; 304(1):44-50. PubMed ID: 24119565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
    Lozniewski A; Lion C; Mory F; Weber M
    Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremic pneumococcal pneumonia associated with macrolide failure.
    Dylewski J; Davidson R
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):39-42. PubMed ID: 16411124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
    Jacobs MR
    Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.
    Low DE
    Infect Dis Clin North Am; 1998 Sep; 12(3):613-30, viii. PubMed ID: 9779381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci.
    Barakett V; Lesage D; Delisle F; Richard G; Petit JC
    Pathol Biol (Paris); 1997 May; 45(5):438-40. PubMed ID: 9296100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
    Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG
    Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus.
    Sacho H; Klugman KP; Koornhof HJ; Ruff P
    J Infect; 1987 Mar; 14(2):188-9. PubMed ID: 3572020
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumonia caused by a pneumococcus resistant to erythromycin and lincomycin. Case report.
    Medoff G
    Mo Med; 1974 Aug; 71(8):496-7. PubMed ID: 4152480
    [No Abstract]   [Full Text] [Related]  

  • 15. Penicillin/ampicillin efficacy among children with severe pneumonia due to penicillin-resistant pneumococcus (MIC=4 microg ml(-1)).
    Nascimento-Carvalho CM; Cardoso MR; Brandileone MC; Ferrero F; Camargos P; Berezin E; Ruvinsky R; Sant'Anna C; March MF; Feris-Iglesias J; Maggi R; Benguigui Y
    J Med Microbiol; 2009 Oct; 58(Pt 10):1390-1392. PubMed ID: 19541781
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumonia due to resistant Streptococcus pneumoniae.
    Täuber MG
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1873-9. PubMed ID: 11153392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 19. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.
    Cunha BA
    Postgrad Med; 2003 Jan; 113(1):42-4, 47-8, 52-4. PubMed ID: 12545592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.